We are proud to announce that EyeCheckup, our AI-powered retinal diagnostic platform, has been featured in a peer-reviewed study published in The Lancet Digital Health—one of the world’s leading journals in digital medicine.
The article presents a new, independent evaluation platform designed to objectively assess the real-world performance of commercial artificial intelligence systems used for diabetic eye disease screening. This platform enables fair, transparent, and unbiased comparison of AI algorithms across large-scale screening programmes, such as those used within national healthcare systems.
EyeCheckup was included among the commercially available AI solutions evaluated within this rigorous framework. Its inclusion reflects the platform’s clinical maturity and readiness for real-world deployment, as well as its ability to deliver consistent and reliable diagnostic performance across diverse patient populations and imaging conditions.
Independent evaluation is critical for building trust in medical AI. Being featured in The Lancet Digital Health highlights EyeCheckup’s commitment to clinical evidence, transparency, and patient safety, and reinforces our mission to support early detection and timely referral of diabetic eye disease at scale.
This recognition further validates EyeCheckup as a robust, clinically relevant AI solution capable of supporting national and regional diabetic eye screening programmes—helping prevent avoidable vision loss through early, accurate diagnosis.
📄 Read the full article in The Lancet Digital Health
https://www.thelancet.com/journals/landig/article/PIIS2589-7500(25)00096-2/fulltext
